Mirum Pharmaceuticals (MIRM) Amortizatization of Intangibles (2019 - 2023)
Mirum Pharmaceuticals (MIRM) recorded quarterly Amortizatization of Intangibles of $29000.0 in Q4 2023, down 87.61% quarter-over-quarter from $234000.0 in Q3 2023, and down 97.15% on a YoY basis from $1.0 million in Q4 2022.
Mirum Pharmaceuticals (MIRM) Amortizatization of Intangibles (2019 - 2023) Analysis & Trends
Mirum Pharmaceuticals' Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $29000.0 for Q4 2023.
- In Q4 2023, Amortizatization of Intangibles fell 97.15% year-over-year to $29000.0; the TTM figure through Dec 2023 stood at $1.7 million (up 1.29% YoY), while the FY2023 annual figure was $1.7 million, up 1.29% from the prior year.
- Amortizatization of Intangibles was $29000.0 for Q4 2023 at Mirum Pharmaceuticals, down from $234000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.3 million in Q2 2023 to a low of -$166000.0 in Q4 2020.
- Historically, Amortizatization of Intangibles has averaged $198150.0 across 5 years, with a median of $76500.0 in 2020.
- The sharpest annual moves came in 2020 and 2023: Amortizatization of Intangibles plunged 230.71% in 2020, then jumped 65800.0% in 2023.
- A 5-year view of Amortizatization of Intangibles shows it stood at $127000.0 in 2019, then slumped by 230.71% to -$166000.0 in 2020, then grew by 10.84% to -$148000.0 in 2021, then soared by 787.16% to $1.0 million in 2022, then slumped by 97.15% to $29000.0 in 2023.
- The last three Amortizatization of Intangibles figures came in at $29000.0 (Q4 2023), $234000.0 (Q3 2023), and $1.3 million (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mirum Pharmaceuticals | 6.29 Bn | 5.90 Bn | 131.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 29,000.00 |
| Dec 31, 2023 | 29,000.00 |
| Sep 30, 2023 | 234,000.00 |
| Sep 30, 2023 | 234,000.00 |
| Jun 30, 2023 | 1.32 Mn |
| Jun 30, 2023 | 1.32 Mn |
| Mar 31, 2023 | 144,000.00 |
| Mar 31, 2023 | 144,000.00 |
| Dec 31, 2022 | 1.02 Mn |
| Dec 31, 2022 | 1.02 Mn |
| Sep 30, 2022 | 583,000.00 |
| Sep 30, 2022 | 583,000.00 |
| Jun 30, 2022 | 2,000.00 |
| Jun 30, 2022 | 2,000.00 |
| Mar 31, 2022 | 101,000.00 |
| Mar 31, 2022 | 101,000.00 |
| Dec 31, 2021 | -148,000.00 |
| Dec 31, 2021 | -148,000.00 |
| Sep 30, 2021 | 263,000.00 |
| Sep 30, 2021 | 263,000.00 |